Follow The Filings

AKBA Akebia Therapeutics Inc.

Health Care, filed as AKEBIA THERAPEUTICS INC (COM), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by AKBA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All AKBA insider trades
  • $87K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. John P. Butler CEO
    Buy
    $87K 69,270 shares at $1.25 +2.1% to stake
    Traded Mar 4 Filed Mar 5
    ↗

Also filed in the last 12 months, not counted as buying or selling: 16 sales to cover taxes, 13 stock grants, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
8-K 3.01 Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,2.03,5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 9 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $194.62M $160.18M $236.2M
Gross profit * $120.47M $97M $196.73M
Gross margin * 61.9% 60.6% 83.3%
Net income -$51.92M -$69.41M -$5.34M
Net margin * -26.7% -43.3% -2.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $118.15M $113.83M $252.96M
Total non-current assets * $123.55M $106.84M $123.61M
Total assets $241.7M $220.67M $376.56M
Total current liabilities $99.87M $80.91M $162.94M
Total non-current liabilities * $172.42M $188.94M $181.02M
Total equity -$30.58M -$49.18M $32.61M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$23.38M -$40.66M $67.99M
Cash from investing $0M -$0.033M -$7.93M
Cash from financing -$25.21M $49.66M $72.93M
Net change in cash -$48.59M $8.97M $132.99M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Q3 2021

Period archive

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf